Evidence map›Paper›PMID 31640978›Full record

ArticleAntimicrobial agents and chemotherapy2019

Reply to Kalil et al., "Is Daptomycin plus Ceftaroline Associated with Better Clinical Outcomes than Standard of Care Monotherapy for Staphylococcus aureus Bacteremia?"

George Sakoulas, Matthew Geriak, Fadi Haddad, Warren Rose, Kerry LaPlante, Marcus Zervos, Ravina Kullar, Victor Nizet

Abstract readLetterComment
PubMed Full text at PMC Publisher
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors.

George SakoulasSharp Memorial Hospital, San Diego, California, USA george.sakoulas@sharp.com.
Matthew GeriakSharp Memorial Hospital, San Diego, California, USA.
Fadi HaddadSharp Grossmont Hospital, La Mesa, California, USA.
Warren RoseUniversity of Wisconsin School of Pharmacy, Madison, Wisconsin, USA.
Kerry LaPlanteUniversity of Rhode Island College of Pharmacy, Kingston, Rhode Island, USA.
Marcus ZervosHenry Ford Hospital, Detroit, Michigan, USA.
Ravina KullarDoctor Evidence, LLC, Santa Monica, California, USA.
Victor NizetUniversity of California San Diego School of Medicine, La Jolla, California, USA.ORCID 0000-0003-3847-0422

Funding

Mechanisms and use of penicillin-binding protein inhibition to optimize cationic peptide anti-MRSA treatmentR01AI132627 · NIAID · UNIVERSITY OF WISCONSIN-MADISON · PI ROSE, WARREN E · 2017 to 2021
$2.1M
NIAID NIH HHS R01 AI132627
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

BacteremiaDaptomycinMethicillin-Resistant Staphylococcus aureusStaphylococcal InfectionsCeftarolineCephalosporinsHumansMethicillinStandard of CareStaphylococcus aureusCeftarolineCephalosporinsDaptomycinMethicillin

Identifiers

PMID31640978
PMCPMC6811430

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.